Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2020 Filed Aug 18, 2020 20:59 UTC |
Bailey William SSVP - Corporate Business Dev
|
Tax withholdingCommon Stock | 634 | $224.25 | $142,174.50 |
DisclosureSEC source: 0001225208-20-010703 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,285 F1 · kind: Withholding of shares by the Company to satisfy certain tax obligations applicable to the payout of Common Stock underlying settlement of 2016 Performance Unit Grant that vested on 8/16/2018, which the reporting person had elected to defer pursuant to the 2005 Stock Incentive Plan. F2 · balance_after: Includes 99 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| August 14, 2020 Filed Oct 2, 2020 21:34 UTC |
WILLIAMS CHRISTOPHER JDirector
|
GrantDeferred Stock Units · Derivative | 43.4594 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012088 · doc4.xml · derivative · entry 1 WILLIAMS CHRISTOPHER J · CIK 0001269949 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,823.4289 Underlying: Common Stock · 43.4594 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 14, 2020 Filed Oct 2, 2020 21:33 UTC |
Tesija Kathryn ADirector
|
GrantDeferred Stock Units · Derivative | 0.2809 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012086 · doc4.xml · derivative · entry 1 Tesija Kathryn A · CIK 0001434187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57.0368 Underlying: Common Stock · 0.2809 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 14, 2020 Filed Oct 2, 2020 21:33 UTC |
WEINER RUSSELL JDirector
|
GrantDeferred Stock Units · Derivative | 25.7539 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012087 · doc4.xml · derivative · entry 1 WEINER RUSSELL J · CIK 0001622458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,228.7422 Underlying: Common Stock · 25.7539 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 14, 2020 Filed Oct 2, 2020 21:32 UTC |
Shattock Matthew JDirector
|
GrantDeferred Stock Units · Derivative | 12.3215 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012085 · doc4.xml · derivative · entry 1 Shattock Matthew J · CIK 0001531361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,501.5925 Underlying: Common Stock · 12.3215 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 14, 2020 Filed Oct 2, 2020 21:32 UTC |
Fleischer Spencer CDirector
|
GrantDeferred Stock Units · Derivative | 42.4665 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-012084 · doc4.xml · derivative · entry 2 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,621.8419 Underlying: Common Stock · 42.4665 shares Expires not disclosed F2 · derivative.exercise_price: 1-for-1 F3 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 14, 2020 Filed Jan 5, 2021 21:20 UTC |
Thomas-Graham PamelaDirector
|
GrantDeferred Stock Units · Derivative | 130.2918 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000256 · doc4.xml · derivative · entry 3 Thomas-Graham Pamela · CIK 0001327431 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,452.747 Underlying: Common Stock · 130.2918 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 14, 2020 Filed Jan 5, 2021 21:20 UTC |
MACKAY A D DAVIDDirector
|
GrantDeferred Stock Units · Derivative | 16.9848 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000255 · doc4.xml · derivative · entry 3 MACKAY A D DAVID · CIK 0001185947 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448.3694 Underlying: Common Stock · 16.9848 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 14, 2020 Filed Jan 5, 2021 21:20 UTC |
Lee EstherDirector
|
GrantDeferred Stock Units · Derivative | 36.1271 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000254 · doc4.xml · derivative · entry 3 Lee Esther · CIK 0001585015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,334.787 Underlying: Common Stock · 36.1271 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 14, 2020 Filed Jan 5, 2021 21:20 UTC |
Carmona Richard HDirector
|
GrantDeferred Stock Units · Derivative | 108.2321 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000252 · doc4.xml · derivative · entry 3 Carmona Richard H · CIK 0001389349 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,974.0322 Underlying: Common Stock · 108.2321 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 14, 2020 Filed Jan 5, 2021 21:20 UTC |
Banse AmyDirector
|
GrantDeferred Stock Units · Derivative | 16.9848 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-000250 · doc4.xml · derivative · entry 3 Banse Amy · CIK 0001550029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448.3694 Underlying: Common Stock · 16.9848 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC |
Mowery Andrew JSVP-Chief Product Supply
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,110 | $0.00 Strike: $84.45 | $0.00 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · derivative · entry 7 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,110 shares Expires 2023-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC |
Mowery Andrew JSVP-Chief Product Supply
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,120 | $0.00 Strike: $72.11 | $0.00 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · derivative · entry 6 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,120 shares Expires 2022-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC |
Mowery Andrew JSVP-Chief Product Supply
|
SaleCommon Stock | 5,775 | $235.27 | $1,358,702.73 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · nonDerivative · entry 5 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,634 F3 · price: This transaction was executed in multiple trades at prices ranging from $234.64 to $235.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes 64 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC |
Mowery Andrew JSVP-Chief Product Supply
|
SaleCommon Stock | 3,682 | $236.16 | $869,549.22 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · nonDerivative · entry 4 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,409 F2 · price: This transaction was executed in multiple trades at prices ranging from $235.69 to $236.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC |
Mowery Andrew JSVP-Chief Product Supply
|
SaleCommon Stock | 3,475 | $236.91 | $823,252.87 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · nonDerivative · entry 3 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,091 F1 · price: This transaction was executed in multiple trades at prices ranging from $236.74 to $237.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC |
Mowery Andrew JSVP-Chief Product Supply
|
Exercise / conversionCommon Stock | 6,110 | $84.45 | $515,989.50 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · nonDerivative · entry 2 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC |
Mowery Andrew JSVP-Chief Product Supply
|
Exercise / conversionCommon Stock | 8,120 | $72.11 | $585,533.20 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · nonDerivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC |
Bailey William SSVP - Corporate Business Dev
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,080 | $0.00 Strike: $151.85 | $0.00 |
DisclosureSEC source: 0001225208-20-010416 · doc4.xml · derivative · entry 5 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,240 Underlying: Common Stock · 3,080 shares Expires 2028-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC |
Bailey William SSVP - Corporate Business Dev
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,005 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-20-010416 · doc4.xml · derivative · entry 4 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,005 Underlying: Common Stock · 9,005 shares Expires 2027-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC |
Bailey William SSVP - Corporate Business Dev
|
SaleCommon Stock | 11,468 | $238.50 | $2,735,118.00 |
DisclosureSEC source: 0001225208-20-010416 · doc4.xml · nonDerivative · entry 3 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,820 Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC |
Bailey William SSVP - Corporate Business Dev
|
Exercise / conversionCommon Stock | 3,080 | $151.85 | $467,698.00 |
DisclosureSEC source: 0001225208-20-010416 · doc4.xml · nonDerivative · entry 2 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 22:22 UTC |
Bailey William SSVP - Corporate Business Dev
|
Exercise / conversionCommon Stock | 9,005 | $135.57 | $1,220,807.85 |
DisclosureSEC source: 0001225208-20-010416 · doc4.xml · nonDerivative · entry 1 Bailey William S · CIK 0001662773 · SVP - Corporate Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 00:01 UTC |
Barral Diego JSVP - GM, International
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,240 | $0.00 Strike: $151.85 | $0.00 |
DisclosureSEC source: 0001225208-20-010371 · doc4.xml · derivative · entry 5 Barral Diego J · CIK 0001737080 · SVP - GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,720 Underlying: Common Stock · 2,240 shares Expires 2028-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 00:01 UTC |
Barral Diego JSVP - GM, International
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,420 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-20-010371 · doc4.xml · derivative · entry 4 Barral Diego J · CIK 0001737080 · SVP - GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,420 Underlying: Common Stock · 4,420 shares Expires 2027-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 00:01 UTC |
Barral Diego JSVP - GM, International
|
SaleCommon Stock | 10,041 | $235.59 | $2,365,595.34 |
DisclosureSEC source: 0001225208-20-010371 · doc4.xml · nonDerivative · entry 3 Barral Diego J · CIK 0001737080 · SVP - GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,130 F1 · price: This transaction was executed in multiple trades at prices ranging from $235.46 to $235.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 00:01 UTC |
Barral Diego JSVP - GM, International
|
Exercise / conversionCommon Stock | 2,240 | $151.85 | $340,144.00 |
DisclosureSEC source: 0001225208-20-010371 · doc4.xml · nonDerivative · entry 2 Barral Diego J · CIK 0001737080 · SVP - GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 04, 2020 Filed Aug 7, 2020 00:01 UTC |
Barral Diego JSVP - GM, International
|
Exercise / conversionCommon Stock | 4,420 | $135.57 | $599,219.40 |
DisclosureSEC source: 0001225208-20-010371 · doc4.xml · nonDerivative · entry 1 Barral Diego J · CIK 0001737080 · SVP - GM, International 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:18 UTC |
Tesija Kathryn ADirector
|
GrantDeferred Stock Units · Derivative | 56.7559 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-009492 · doc4.xml · derivative · entry 1 Tesija Kathryn A · CIK 0001434187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56.7559 Underlying: Common Stock · 56.7559 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:18 UTC |
WILLIAMS CHRISTOPHER JDirector
|
GrantDeferred Stock Units · Derivative | 145.8723 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-009491 · doc4.xml · derivative · entry 2 WILLIAMS CHRISTOPHER J · CIK 0001269949 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,779.9695 Underlying: Common Stock · 145.8723 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:18 UTC |
WEINER RUSSELL JDirector
|
GrantDeferred Stock Units · Derivative | 117.3816 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-009490 · doc4.xml · derivative · entry 2 WEINER RUSSELL J · CIK 0001622458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,202.9883 Underlying: Common Stock · 117.3816 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:17 UTC |
Shattock Matthew JDirector
|
GrantDeferred Stock Units · Derivative | 117.3816 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-009489 · doc4.xml · derivative · entry 2 Shattock Matthew J · CIK 0001531361 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,489.271 Underlying: Common Stock · 117.3816 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F4 · kind: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. F3 · derivative.exercise_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F3 · derivative.expiration_date: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:16 UTC |
Fleischer Spencer CDirector
|
GrantCommon Stock | 140 | $219.37 | $30,711.80 |
DisclosureSEC source: 0001225208-20-009488 · doc4.xml · nonDerivative · entry 1 Fleischer Spencer C · CIK 0001235824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317 F1 · kind: Receipt of Common Stock in lieu of quarterly director's fee. Read SEC document |
| June 29, 2020 Filed Jul 2, 2020 01:33 UTC |
Banks ChauSVP - Chief Info Officer
|
GrantCommon Stock | 1,378 | $217.58 | $299,825.24 |
DisclosureSEC source: 0001225208-20-009324 · doc4.xml · nonDerivative · entry 1 Banks Chau · CIK 0001816462 · SVP - Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,378 F1 · kind: The Restricted Stock Units will vest in 3 installments - 1/3 on each of the first, second and third anniversaries of the grant date. Read SEC document |
| June 29, 2020 Filed Jul 1, 2020 21:21 UTC |
Banks ChauChief Info Officer
|
GrantCommon Stock | 1,378 | $217.58 | $299,825.24 |
DisclosureSEC source: 0001816462-20-000002 · primary_doc.xml · nonDerivative · entry 1 Banks Chau · CIK 0001816462 · Chief Info Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,378 F1 · kind: The Restricted Stock Units will vest in 3 installments: 1/3 on each of the first, second and third anniversaries of the grant date. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,360 | $0.00 Strike: $151.85 | $0.00 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · derivative · entry 14 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,080 Underlying: Common Stock · 3,360 shares Expires 2028-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,803 | $0.00 Strike: $111.60 | $0.00 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · derivative · entry 13 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,803 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,602 | $0.00 Strike: $123.09 | $0.00 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · derivative · entry 12 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,868 Underlying: Common Stock · 11,602 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 8,190 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · derivative · entry 11 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,190 Underlying: Common Stock · 8,190 shares Expires 2027-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
SaleCommon Stock | 9,980 | $198.06 | $1,976,685.71 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · nonDerivative · entry 9 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,989 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on March 10, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F6 · price: This transaction was executed in multiple trades at prices ranging from $197.31 to $198.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
SaleCommon Stock | 6,671 | $198.59 | $1,324,823.24 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · nonDerivative · entry 8 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,969 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on March 10, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F5 · price: This transaction was executed in multiple trades at prices ranging from $198.33 to $198.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
SaleCommon Stock | 6,569 | $196.74 | $1,292,400.83 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · nonDerivative · entry 7 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,640 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on March 10, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F4 · price: This transaction was executed in multiple trades at prices ranging from $196.27 to $197.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
SaleCommon Stock | 2,379 | $195.77 | $465,737.54 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · nonDerivative · entry 6 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,209 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on March 10, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F3 · price: This transaction was executed in multiple trades at prices ranging from $195.24 to $196.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
SaleCommon Stock | 233 | $194.13 | $45,233.41 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · nonDerivative · entry 5 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,588 F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on March 10, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. F2 · price: This transaction was executed in multiple trades at prices ranging from $194.00 to $194.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
Exercise / conversionCommon Stock | 3,360 | $151.85 | $510,216.00 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · nonDerivative · entry 4 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on March 10, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
Exercise / conversionCommon Stock | 3,803 | $111.60 | $424,414.80 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · nonDerivative · entry 3 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on March 10, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
Exercise / conversionCommon Stock | 8,190 | $135.57 | $1,110,318.30 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · nonDerivative · entry 2 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,658 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on March 10, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 23:42 UTC |
GARNER DENISESVP - Chief Innovation Officer
|
Exercise / conversionCommon Stock | 11,602 | $123.09 | $1,428,090.18 |
DisclosureSEC source: 0001225208-20-008821 · doc4.xml · nonDerivative · entry 1 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on March 10, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:34 UTC |
Jacobsen Kevin BEVP - Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,630 | $0.00 Strike: $89.82 | $0.00 |
DisclosureSEC source: 0001225208-20-007831 · doc4.xml · derivative · entry 10 Jacobsen Kevin B · CIK 0001735465 · EVP - Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,630 shares Expires 2024-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:34 UTC |
Jacobsen Kevin BEVP - Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,585 | $0.00 Strike: $84.45 | $0.00 |
DisclosureSEC source: 0001225208-20-007831 · doc4.xml · derivative · entry 9 Jacobsen Kevin B · CIK 0001735465 · EVP - Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,585 shares Expires 2023-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.